换一批
换一批Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.
第一作者：
Peter,Lang
第一单位：
Department of Pediatric Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany. prlang@med.uni-tuebingen.de
作者：
主题词
抗体(Antibodies);抗体依赖细胞细胞毒性(Antibody-Dependent Cell Cytotoxicity);抗原, CD19(Antigens, CD19);儿童(Child);细胞毒性试验, 免疫(Cytotoxicity Tests, Immunologic);人类(Humans);杀伤细胞, 天然(Killer Cells, Natural);淋巴细胞去除术(Lymphocyte Depletion);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);重组融合蛋白质类(Recombinant Fusion Proteins);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);移植, 同种(Transplantation, Homologous)
DOI
10.1182/blood-2003-05-1735
PMID
14764538
发布时间
2021-02-06
- 浏览13
Blood
3982-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
